India (Commonwealth Union)_ Apollo Hospitals, Jubilee Hills, Hyderabad will soon launch a Department for Regenerative Medicine in collaboration with the internationally renowned traumatology and regenerative techniques expert Prof. Enrico Castellacci. He is a surgeon specialized in Orthopaedics, Traumatology, and Sports Medicine. Other honorable positions held by him are National President of the Italian Football Doctors’ Association; Former Medical Director of the Italian National Football Team, which bagged the 2006 World Cup; and former Head of the Medical Staff of the Chinese National Soccer Team.
Regenerative medicine is the medicine of the future. Instead of treating symptoms with drugs and treatments, the regenerative medicine replaces or regenerates tissues or organs destroyed by illness, injury, age or other factors. In addition to assuring the repair of larger cartilage abnormalities, this single-stage procedure provides huge benefits to patients including joint preservation and minimal invasive injury. In the majority cases, this FDA-approved treatment restores the joint to normal status.
Prof. Castellacci is an expert in the field of orthopedic traumatology. Platelet-rich Plasma and mesenchymal stem cells are used in the therapy. Apollo Hospitals will implement these treatments in India to treat cartilage, muscle, and tendon issues in the different joints, as well as traumatic and degenerative illnesses. These therapies will be provided as part of daycare services.
The 350-bed Apollo Hospital Hyderabad is a multi-specialty facility with over 50 specialties and super-specialties, 10 centers of excellence, research, education, world-class equipment, and information technology. The hospital premises covers an area of 190,000 square feet. All of these top-class features have elevated Apollo Hyderabad to the level of the greatest in the world. Additionally, the present surgical success rates of the hospital are 98.8% for 10,000 cardiac operations; 98.9% for 12,000 Interventional cardiac operations; and 95% for 600 kidney transplants.
